期刊文献+

EZH2在维吾尔族妇女宫颈癌中的表达及临床意义 被引量:1

Expression and significance of EZH2 in cervical cancers of Uygur women
下载PDF
导出
摘要 目的观察EZH2(Enhancer of Zeste Homolog 2)蛋白在维吾尔族妇女宫颈癌和对照组中的表达,探讨其与维吾尔族妇女宫颈癌临床病理因素之间的关系。方法应用免疫组化和Western blot法检测维吾尔族妇女正常宫颈或慢性宫颈炎和宫颈癌组织中EZH2蛋白的表达。结果用免疫组化检测出EZH2在维吾尔族正常宫颈和宫颈癌中的阳性率分别为28.89%和61.02%,Western blot法检测显示EZH2/GADPH在宫颈癌中为1.172 2,对照组为0.994 4,差异均具有统计学意义。宫颈癌组中EZH2与年龄、临床分期、病理分级均无关。结论 EZH2在维吾尔族妇女宫颈癌中过表达,在宫颈癌的发生、发展过程中起一定作用,其检测对宫颈癌的早期诊断有一定的参考价值。 Purpose To explore the expression and significance of EZH2 in cervical cancers of Uygur.Methods Cases of cervical cancer and normal cervical tissues were examined by immunohistochemical staining and Western blot method.Results The immunohistochemical analysis demonstrated that the positive rates of EZH2 in normal cervical tissue group and cervical cancer groups were 28.89% and 61.02% respectively.The Western blot analysis demonstrated that EZH2/GADPH in normal cervical tissue group and cervical cancer group was 1.1722 and 0.9944 respectively.The difference among cervical cancer and normal cervical tissue group was significant.The expressions of EZH2 were not related to age,clinical stages and histological grade.Conclusion EZH2 overexpression correlates with cervical carcinogenesis and tumor progression.EZH2 maybe play an important role in the oncogenesis and progression of cervical cancer.Detection of EZH2 gene has positive effects on early diagnosis in cervical cancers.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第3期292-294,共3页 Chinese Journal of Clinical and Experimental Pathology
基金 新疆维吾尔自治区教育厅高校科研计划(XJEDU2009I23)
关键词 子宫颈肿瘤 维吾尔族 EZH2基因 免疫组织化学 蛋白质免疫印记法 cervical neoplasmas Uygur EZH2 immunohistochemistry Western blot
  • 相关文献

参考文献5

二级参考文献11

  • 1罗凌青,潘铁成.非小细胞肺癌组织中KAI1/CD_(82)和P53的表达及临床意义[J].中国现代医学杂志,2007,17(3):264-268. 被引量:3
  • 2Hanson RD, Hess JL, Yu BD et al. Mammalian Trithorax and Polycomb - group homo logues are antagonistic regulators of homeotic development [J] .PNAS, 1999, 25 (96): 14372
  • 3Julie L, Gu S. Polycomb group genes as epigenetic regulators of normal and leukemic h emopoiesis [J] . J Ex Hematol, 2003, 3:567
  • 4Tonini T, Bagella L, Andrilli G et al. Ezh2 reduces the ability of HDAC1 -dependent pRb2/p130 transcriptional repression of cyclin [J]. Oncogene, 2004, 23 (28): 4930
  • 5Bracken AP, Pasini D, Capra M et al. EZH2 is down stream of the pRB -E2F pathway, essential for proliferation and amplified in cancer [J].EMBO, 2003, 22 (20): 5323
  • 6Ingeborg M, Bachmann, Ole J Halvorsen et al. EZH2 Expresion is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate and breast [J] . Journal of clinical oncology, 2006, 2 (24) : 268
  • 7Jacobs J L, van Lohuizen M. Pol combre ression : from cellular rolifeation and cancer [ J] . J Biochim Biophys Acta, 2002, 1602:151
  • 8Carlos Cardoso, Cecile Minon, Gilles Hetet et al. The human EZH2 gene: genomic or anisatin and revised mapping in7q35 within the critical reion for maligment myeloid disorders [J] . Eur J Hum Genetics,2000, 8:174
  • 9Varambally S, Dhanasekaran SM, Ming H et al. The poly - comb group protein EZH2 is involved in progression of prostate cancer [J] . Nature, 2002, 419:624
  • 10Raaphorst FM, Meijer C J, Fieret E et al. poorly differentiated breast carcinoma is associated with increased expressionof the human polycomb group EZH2 gene [J]. Neoplasia, 2003, 5 (6): 481

共引文献79

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部